Intra-Cellular Therapies, Inc. (ITCI)
NASDAQ: ITCI · Real-Time Price · USD
128.60
+0.06 (0.05%)
Feb 21, 2025, 4:00 PM EST - Market closed
Intra-Cellular Therapies Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Feb '25 Feb 21, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 13,663 | 8,855 | 6,893 | 5,012 | 4,264 | 2,549 | |
| Market Cap Growth | 28.47% | 28.47% | 37.53% | 17.54% | 67.27% | 34.44% | |
| Enterprise Value | 12,679 | 7,866 | 6,417 | 4,409 | 3,813 | 1,856 | |
| Last Close Price | 128.60 | 83.52 | 71.62 | 52.92 | 52.34 | 31.80 | |
| PS Ratio | 19.48 | 13.01 | 14.84 | 20.02 | 50.88 | 111.73 | |
| PB Ratio | 11.90 | 7.71 | 11.65 | 7.64 | 10.20 | 3.88 | |
| P/TBV Ratio | 7.71 | 7.71 | 11.65 | 7.64 | 10.20 | 3.88 | |
| EV/Sales Ratio | 18.62 | 11.55 | 13.82 | 17.62 | 45.50 | 81.37 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.03 | 0.03 | 0.06 | 0.04 | |
| Asset Turnover | 0.65 | 0.65 | 0.63 | 0.40 | 0.14 | 0.05 | |
| Inventory Turnover | 3.00 | 3.00 | 12.03 | 9.74 | 12.91 | - | |
| Quick Ratio | 5.68 | 5.68 | 4.95 | 8.01 | 8.11 | 18.13 | |
| Current Ratio | 6.36 | 6.36 | 5.41 | 8.87 | 8.76 | 18.75 | |
| Return on Equity (ROE) | -8.58% | -8.58% | -22.39% | -47.72% | -52.87% | -53.30% | |
| Return on Assets (ROA) | -6.96% | -6.96% | -13.43% | -26.47% | -29.58% | -29.84% | |
| Return on Capital (ROIC) | -8.23% | -8.23% | -15.51% | -29.44% | -31.62% | -31.97% | |
| Earnings Yield | -0.55% | -0.84% | -2.03% | -5.11% | -6.66% | -8.91% | |
| FCF Yield | - | -1.81% | -5.41% | -6.09% | -9.04% | |
| Buyback Yield / Dilution | -7.56% | -7.56% | -1.95% | -15.74% | -15.47% | -27.50% | |
| Total Shareholder Return | -7.56% | -7.56% | -1.95% | -15.74% | -15.47% | -27.50% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.